These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30730124)

  • 1. Aripiprazole: impulse control disorders. Pathological gambling.
    Prescrire Int; 2016 Nov; 25(176):271. PubMed ID: 30730124
    [No Abstract]   [Full Text] [Related]  

  • 2. Partial dopamine agonist-induced pathological gambling and impulse-control deficit on low-dose aripiprazole.
    Peterson E; Forlano R
    Australas Psychiatry; 2017 Dec; 25(6):614-616. PubMed ID: 28696131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Gambling Disorder and Impulse Control Disorder With Aripiprazole, Pramipexole, and Ropinirole: A Pharmacoepidemiologic Study.
    Etminan M; Sodhi M; Samii A; Procyshyn RM; Guo M; Carleton BC
    J Clin Psychopharmacol; 2017 Feb; 37(1):102-104. PubMed ID: 27930495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aripiprazole and impulse-control disorders in high-risk patients.
    Mohan T; Dolan S; Mohan R; Dawson J
    Asian J Psychiatr; 2017 Jun; 27():67-68. PubMed ID: 28558898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological gambling and the treatment of psychosis with aripiprazole: case reports.
    Smith N; Kitchenham N; Bowden-Jones H
    Br J Psychiatry; 2011 Aug; 199(2):158-9. PubMed ID: 21804151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aripiprazole and Impulse-Control Disorders: A Recent FDA Warning and a Case Report.
    Dhillon R; Bastiampillai T; Cao CZ; Eckert TG; Tibrewal P
    Prim Care Companion CNS Disord; 2017 Jan; 19(1):. PubMed ID: 28102975
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk of Pathological Gambling and Impulse Control Disorders With Dopamine Agonists: A Retrospective Cohort Study.
    Sodhi M; Etminan M; Carleton B; Samii A
    J Clin Psychopharmacol; 2019; 39(6):675-676. PubMed ID: 31688453
    [No Abstract]   [Full Text] [Related]  

  • 8. Aripiprazole induced Impulse Control Disorders: Where do we stand?
    Mahapatra A; Sharma P; Sagar R
    Asian J Psychiatr; 2016 Oct; 23():128-130. PubMed ID: 27969070
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypersexuality induced by Aripiprazole: Two case reports and review of the literature.
    Reddy B; Ali M; Guruprasad S; Das S
    Asian J Psychiatr; 2018 Dec; 38():57-59. PubMed ID: 29107566
    [No Abstract]   [Full Text] [Related]  

  • 10. Escalation of Gambling Associated With Aripiprazole: A Case Report and Literature Review.
    Giri YR; Peteru SR
    J Psychiatr Pract; 2019 Mar; 25(2):139-145. PubMed ID: 30849063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological Gambling Associated With Aripiprazole or Dopamine Replacement Therapy: Do Patients Share the Same Features? A Review.
    Grall-Bronnec M; Sauvaget A; Perrouin F; Leboucher J; Etcheverrigaray F; Challet-Bouju G; Gaboriau L; Derkinderen P; Jolliet P; Victorri-Vigneau C
    J Clin Psychopharmacol; 2016 Feb; 36(1):63-70. PubMed ID: 26658263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two Cases of De Novo Pathological Gambling Associated With Aripiprazole.
    Chen HY; Ma CH; Liu CC
    Clin Neuropharmacol; 2019; 42(3):101-102. PubMed ID: 31082834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aripiprazole-induced behavioural disturbance related to impulse control in a clinical setting.
    Kodama M; Hamamura T
    Int J Neuropsychopharmacol; 2010 May; 13(4):549-51. PubMed ID: 19917149
    [No Abstract]   [Full Text] [Related]  

  • 14. [Aripiprazole, gambling disorder and compulsive sexuality].
    Mété D; Dafreville C; Paitel V; Wind P
    Encephale; 2016 Jun; 42(3):281-3. PubMed ID: 26923999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aripiprazole and impulse control disorders: higher risk with the intramuscular depot formulation?
    Lertxundi U; Hernandez R; Medrano J; Domingo-Echaburu S; Garcia M; Aguirre C
    Int Clin Psychopharmacol; 2018 Jan; 33(1):56-58. PubMed ID: 28777129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System.
    Fusaroli M; Raschi E; Giunchi V; Menchetti M; Rimondini Giorgini R; De Ponti F; Poluzzi E
    Int J Neuropsychopharmacol; 2022 Sep; 25(9):727-736. PubMed ID: 35639870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two Adolescent Cases of Psychotropic-Related Nonaffective Oniomania.
    Naguy A; Abdelhakim W; Al-Tajali A
    J Child Adolesc Psychopharmacol; 2018 May; 28(4):295-296. PubMed ID: 29240460
    [No Abstract]   [Full Text] [Related]  

  • 18. Case Reports of Aripiprazole and Problematic Gambling in Schizophrenia: A Critical Review of the Evidence.
    Lachance A; Corbeil O; Corbeil S; Chalifour G; Breault AS; Roy MA; Demers MF
    J Clin Psychopharmacol; 2019; 39(4):393-397. PubMed ID: 31206391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial agonist therapy in schizophrenia: relevance to diminished criminal responsibility.
    Gavaudan G; Magalon D; Cohen J; Lançon C; Léonetti G; Pélissier-Alicot AL
    J Forensic Sci; 2010 Nov; 55(6):1659-62. PubMed ID: 20579229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological Gambling and Compulsive Eating Associated with Long-Acting Injectable Aripiprazole: A Case Report.
    Golouh V; Celofiga A
    Psychiatr Danub; 2021; 33(3):373-375. PubMed ID: 34795185
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.